Kemp Brandon A, Howell Nancy L, Gildea John J, Padia Shetal H
Division of Endocrinology and Metabolism (B.A.K., N.L.H., S.H.P.), Department of Medicine, and Department of Pathology (J.J.G.), University of Virginia School of Medicine, Charlottesville, Virginia 22908-1414.
Endocrinology. 2014 Jul;155(7):2658-66. doi: 10.1210/en.2013-2177. Epub 2014 May 5.
Excess weight gain contributes up to 65% of the risk of primary hypertension, and the increase in blood pressure in response to high-fat diet (HFD) is preceded by significant increases in renal tubular sodium (Na(+)) reabsorption. In normal rats, intrarenal ghrelin infusion increases distal nephron-dependent Na(+) reabsorption via activation of the intrarenal ghrelin receptor (GHSR). This study focusses on the role of intrarenal GHSR-mediated Na(+) reabsorption in HFD-induced hypertension. Dahl salt-sensitive rats received standard diet or HFD for 6 weeks. Rats underwent uninephrectomy and osmotic minipump implantation for chronic intrarenal delivery of vehicle (0.25 μL/h × 28 d), selective GHSR antagonist [D-Lys-3]-growth hormone releasing peptide-6 (0.2μM/d), or GHSR inverse agonist [D-Arg(1), D-Phe(5), D-Trp(7,9), Leu(11)]-substance P (SUB-P) (3.6μM/d). HFD rats with vehicle pumps had significantly increased renal GHSR expression compared with standard diet (0.092 ± 0.005 vs 0.065 ± 0.004 arbitrary units; P < .05), whereas acyl ghrelin levels were similar (16.3±6.2 vs 15.7±8.7 pg/g tissue). HFD rats with vehicle pumps became hypertensive after 2 weeks (P < .05) and showed a significant reduction in 24-hour urine Na(+) before hypertension. At this time, these rats showed an increase in collecting duct α-epithelial Na(+) channel, thereby providing a potential mechanism for the excess Na(+) reabsorption. In contrast, HFD rats with [D-Lys-3]-growth hormone releasing peptide-6 or SUB-P pumps never became hypertensive and did not show the reduction in urine Na(+). Because SUB-P blocks the constitutive, but not ghrelin-dependent, activity of the GHSR, and HFD-induced α-epithelial Na(+) channel up-regulation was abolished during GHSR antagonism, these data suggest that HFD increases the constitutive activity of renal GHSR to increase Na(+) reabsorption and induce hypertension in rats.
体重过度增加对原发性高血压风险的贡献率高达65%,在高脂饮食(HFD)导致血压升高之前,肾小管钠(Na⁺)重吸收会显著增加。在正常大鼠中,肾内注射胃饥饿素可通过激活肾内胃饥饿素受体(GHSR)增加远端肾单位依赖性Na⁺重吸收。本研究聚焦于肾内GHSR介导的Na⁺重吸收在HFD诱导的高血压中的作用。Dahl盐敏感大鼠接受标准饮食或HFD喂养6周。大鼠接受单侧肾切除术并植入渗透微型泵,用于长期肾内输注载体(0.25 μL/h×28天)、选择性GHSR拮抗剂[D-Lys-3]-生长激素释放肽-6(0.2μM/d)或GHSR反向激动剂[D-Arg(1), D-Phe(5), D-Trp(7,9), Leu(11)]-P物质(SUB-P)(3.6μM/d)。与标准饮食组相比,接受载体泵的HFD大鼠肾GHSR表达显著增加(0.092±0.005对0.065±0.004任意单位;P<0.05),而酰基胃饥饿素水平相似(16.3±6.2对15.7±8.7 pg/g组织)。接受载体泵的HFD大鼠在2周后出现高血压(P<0.05),且在高血压出现前24小时尿Na⁺显著减少。此时,这些大鼠集合管α-上皮钠通道增加,从而为过量的Na⁺重吸收提供了一种潜在机制。相比之下,接受[D-Lys-3]-生长激素释放肽-6或SUB-P泵的HFD大鼠从未出现高血压,且尿Na⁺也未减少。由于SUB-P可阻断GHSR的组成性活性,但不阻断胃饥饿素依赖性活性,且在GHSR拮抗期间HFD诱导的α-上皮钠通道上调被消除,这些数据表明HFD增加了肾GHSR的组成性活性,以增加Na⁺重吸收并诱导大鼠高血压。